Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

[1]  P. Damman,et al.  MULTIPLE BIOMARKERS AT ADMISSION SIGNIFICANTLY IMPROVE THE PREDICTION OF MORTALITY IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION , 2013 .

[2]  G. Stone,et al.  Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. , 2010, JACC. Cardiovascular interventions.

[3]  R. Jaffe,et al.  Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. , 2010, JACC. Cardiovascular interventions.

[4]  J. Tijssen,et al.  Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention. , 2010, The American journal of cardiology.

[5]  J. Tijssen,et al.  Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary int , 2010, The American journal of cardiology.

[6]  G. Stone,et al.  QUANTIFICATION OF AMPLITUDE, SPEED AND COMPLETENESS OF ST-SEGMENT RECOVERY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: WHAT IS THE “BEST ST” RECOVERY TO PREDICT CLINICAL OUTCOME? , 2010 .

[7]  R. Kim,et al.  Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. , 2009, Journal of the American College of Cardiology.

[8]  W. J. Rohling,et al.  Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study , 2009, Heart.

[9]  J. Tijssen,et al.  Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial in , 2009, JACC. Cardiovascular interventions.

[10]  P. Raskin,et al.  Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. , 2008, Circulation.

[11]  M. Sabatine,et al.  Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). , 2008, The American journal of cardiology.

[12]  Jong Chun Park,et al.  Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction. , 2007, The American journal of cardiology.

[13]  E. Antman,et al.  The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. , 2007, Journal of the American College of Cardiology.

[14]  K. Eagle,et al.  Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. , 2007, JAMA.

[15]  Albert Schömig,et al.  Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. , 2004, Circulation.

[16]  Felix Zijlstra,et al.  Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade , 2003, Circulation.

[17]  George Dangas,et al.  Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. , 2002, Journal of the American College of Cardiology.

[18]  Salim Yusuf,et al.  The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. , 2002, Journal of the American College of Cardiology.

[19]  H. Suryapranata,et al.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.

[20]  D. DeMets,et al.  Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.

[21]  K. Wegscheider,et al.  Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.

[22]  R. Califf,et al.  Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. , 2001, Journal of the American College of Cardiology.